Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (T0B1)

被引:36
作者
Jiao, Yang [1 ]
Sun, Ke-kang [1 ]
Zhao, Lin [1 ]
Xu, Jia-ying [1 ]
Wang, Li-li [1 ]
Fan, Sai-jun [1 ]
机构
[1] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Key Lab Radiat Biol, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
human lung cancer cells; transducer of ErbB-2.1 (T0B1); PTEN; carcinogenesis; metastasis; RNA interference; ADENOVIRUS-MEDIATED EXPRESSION; BREAST-CANCER; BETA-CATENIN; TOB; PTEN; CARCINOMA; INVASION; EGFR; GENE; PROTEIN;
D O I
10.1038/aps.2011.163
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Aim: To investigate the effects of the transducer of ErbB-2.1 (1081) on the proliferation, migration and invasion of human lung cancer cells in vitro. Methods: Human lung cancer cell lines (95-D, A549, NCl-H1299, NCl-H1975, NCl-H661, NCl-H446, NCl-H1395, and Calu-3) and the normal human bronchial epithelial (HBE) cell line were tested. The expression levels of TOB1 in the cells were determined with Western blot and RT-PCR analyses. TOB1-overexpressing cell line 95-D/TOB1 was constructed using lipofectamine-induced 1081 recombinant plasmid transfection and selective G418 cell culture. The A549 cells were transcend-transfected with TOB1-siRNA. MTT assay, flow cytometry and Western blot analysis were used to examine the effects of TOB1 on cancer cell proliferation and wound healing. Transwell invasive assay was performed to evaluate the effects of TOB1 on cancer cell migration and invasion. The activity of MMP2 and MMP9 was measured using gelatin zymography assay. Results: The expression levels of 1061 in the 8 human lung cancer cell lines were significantly lower than that in HBE cells. 1081 overexpression inhibited the proliferation of 95-D cells, whereas TOB1 knockdown with TOB1-sIRNA promoted the growth of A549 cells. Decreased cell migration and invasion were detected in 95-D/TOB1 cells, and the suppression of TOB1 enhanced the metastasis in A549 cells. TOB1 overexpression not only increased the expression of the phosphatase and tensin homolog (PTEN), an important tumor suppressor, but also regulated the downstream effectors in the PI3K/PTEN signaling pathway, including Akt, ERK1/2, etc. In contrast, decreased expression of 1081 oppositely regulated the expression of these factors. TOB1 also regulates the gelatinase activity of MMP2 and MMP9 in lung cancer cells. Conclusion: The results demonstrate that the PI3K/PTEN pathway, which is essential for carcinogenesis, angiogenesis, and metastasis, may be one of the possible signaling pathways for regulation of proliferation and metastasis of human lung cancer cells by TOB1 in vitro.
引用
收藏
页码:250 / 260
页数:11
相关论文
共 56 条
[1]
The Mammalian Target of Rapamycin Pathway Is Widely Activated Without PTEN Deletion in Renal Cell Carcinoma Metastases [J].
Abou Youssif, Tamer ;
Fahmy, Mona Alam ;
Koumakpayi, Ismael Herve ;
Ayala, Fernanda ;
Al Marzooqi, Saeeda ;
Chen, Guangyong ;
Tamboli, Pheroze ;
Squire, Jeremy ;
Tanguay, Simon ;
Sircar, Kanishka .
CANCER, 2011, 117 (02) :290-300
[2]
Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients [J].
Andjelkovic, Tijana ;
Bankovic, Jasna ;
Stojsic, Jelena ;
Milinkovic, Vedrana ;
Podolski-Renic, Ana ;
Ruzdijic, Sabera ;
Tanic, Nikola .
TRANSLATIONAL RESEARCH, 2011, 157 (01) :19-28
[3]
PTEN, more than the AKT pathway [J].
Blanco-Aparicio, Carmen ;
Renner, Oliver ;
Leal, Juan F. M. ;
Carnero, Amancio .
CARCINOGENESIS, 2007, 28 (07) :1379-1386
[4]
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma [J].
Capodanno, Alessandra ;
Camerini, Andrea ;
Orlandini, Cinzia ;
Baldini, Editta ;
Resta, Maria Letizia ;
Bevilacqua, Generoso ;
Collecchi, Paola .
HUMAN PATHOLOGY, 2009, 40 (10) :1408-1417
[5]
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer -: Safety efficacy, and biologic activity of a novel gene-therapy approach [J].
Cristofanilli, Massimo ;
Krishnamurthy, Savitri ;
Guerra, Laura ;
Broglio, Kristine ;
Arun, Banu ;
Booser, Daniel J. ;
Menander, Kerstin ;
Van Wart Hood, Jill ;
Valero, Vicente ;
Hortobagyi, Gabriel N. .
CANCER, 2006, 107 (05) :935-944
[6]
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer [J].
De Roock, Wendy ;
De Vriendt, Veerle ;
Normanno, Nicola ;
Ciardiello, Fortunato ;
Tejpar, Sabine .
LANCET ONCOLOGY, 2011, 12 (06) :594-603
[7]
Generation of tolerogenic dendritic cells via the E-cadherin/β-catenin-signaling pathway [J].
Fu, Chunmei ;
Jiang, Aimin .
IMMUNOLOGIC RESEARCH, 2010, 46 (1-3) :72-78
[8]
PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity [J].
Gildea, JJ ;
Herlevsen, M ;
Harding, MA ;
Gulding, KM ;
Moskaluk, CA ;
Frierson, HF ;
Theodorescu, D .
ONCOGENE, 2004, 23 (40) :6788-6797
[9]
TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer [J].
Helms, Mike W. ;
Kemming, Dirk ;
Contag, Christopher H. ;
Pospisil, Heike ;
Bartkowiak, Kai ;
Wang, Alice ;
Chang, Sheng-Yung ;
Buerger, Horst ;
Brandt, Burkhard H. .
CANCER RESEARCH, 2009, 69 (12) :5049-5056
[10]
EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer [J].
Ho-Pun-Cheung, Alexandre ;
Assenat, Eric ;
Bascoul-Mollevi, Caroline ;
Bibeau, Frederic ;
Boissiere-Michot, Florence ;
Cellier, Dominic ;
Azria, David ;
Rouanet, Philippe ;
Senesse, Pierre ;
Ychou, Marc ;
Lopez-Crapez, Evelyne .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (12) :2938-2946